Share-based Payment Arrangement, Expense of MEDIFAST INC from 31 Dec 2019 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
- Summary
-
MEDIFAST INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
- MEDIFAST INC Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $2,172,000, a 1.9% increase year-over-year.
- MEDIFAST INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $7,639,000, a 3.7% increase year-over-year.
- MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2025 was $7,639,000, a 3.7% increase from 2024.
- MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2024 was $7,363,000, a 10% decline from 2023.
- MEDIFAST INC annual Share-based Payment Arrangement, Expense for 2023 was $8,188,000, a 26% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
MEDIFAST INC Quarterly Share-based Payment Arrangement, Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $7,639,000 | $2,172,000 | +$40,000 | +1.9% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2025 | $7,599,000 | $910,000 | +$304,000 | +50% | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 03 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $7,295,000 | $2,627,000 | +$173,000 | +7% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 04 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $7,122,000 | $1,930,000 | -$241,000 | -11% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 28 Apr 2025 | 2025 | Q1 |
| Q4 2024 | $7,363,000 | $2,132,000 | -$261,000 | -11% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2024 | $7,624,000 | $606,000 | -$2,069,000 | -77% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 03 Nov 2025 | 2025 | Q3 |
| Q2 2024 | $9,693,000 | $2,454,000 | -$60,000 | -2.4% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 04 Aug 2025 | 2025 | Q2 |
| Q1 2024 | $9,753,000 | $2,171,000 | +$1,565,000 | +258% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 28 Apr 2025 | 2025 | Q1 |
| Q4 2023 | $8,188,000 | $2,393,000 | -$557,000 | -19% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2023 | $8,745,000 | $2,675,000 | -$288,000 | -9.7% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 04 Nov 2024 | 2024 | Q3 |
| Q2 2023 | $9,033,000 | $2,514,000 | -$351,000 | -12% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 05 Aug 2024 | 2024 | Q2 |
| Q1 2023 | $9,384,000 | $606,000 | -$1,669,000 | -73% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 29 Apr 2024 | 2024 | Q1 |
| Q4 2022 | $11,053,000 | $2,950,000 | -$288,000 | -8.9% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 18 Feb 2025 | 2024 | FY |
| Q3 2022 | $11,341,000 | $2,963,000 | +$694,000 | +31% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 06 Nov 2023 | 2023 | Q3 |
| Q2 2022 | $10,647,000 | $2,865,000 | +$667,000 | +30% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 07 Aug 2023 | 2023 | Q2 |
| Q1 2022 | $9,980,000 | $2,275,000 | +$77,000 | +3.5% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 01 May 2023 | 2023 | Q1 |
| Q4 2021 | $9,903,000 | $3,238,000 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 20 Feb 2024 | 2023 | FY | ||
| Q3 2021 | $2,269,000 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 03 Nov 2022 | 2022 | Q3 | |||
| Q2 2021 | $2,198,000 | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 03 Aug 2022 | 2022 | Q2 | |||
| Q1 2021 | $2,198,000 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 02 May 2022 | 2022 | Q1 |
MEDIFAST INC Annual Share-based Payment Arrangement, Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $7,639,000 | +$276,000 | +3.7% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2024 | $7,363,000 | -$825,000 | -10% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2023 | $8,188,000 | -$2,865,000 | -26% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2022 | $11,053,000 | +$1,150,000 | +12% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 18 Feb 2025 | 2024 | FY |
| 2021 | $9,903,000 | +$3,107,000 | +46% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 20 Feb 2024 | 2023 | FY |
| 2020 | $6,796,000 | +$2,276,000 | +50% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 21 Feb 2023 | 2022 | FY |
| 2019 | $4,520,000 | 01 Jan 2019 | 31 Dec 2019 | 10-K | 23 Feb 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.